Editorial introductions

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Indranil DasguptaIndranil DasguptaProfessor Dasgupta is a clinical academic in nephrology and hypertension. He works as a consultant nephrologist and hypertension specialist. He is the current Chair of British and Irish Hypertension Society Research Committee. He has a wide portfolio of research; his interests include treatment resistant hypertension, diabetic kidney disease, cognitive impairment in CKD, blood pressure and volume management in dialysis among others. He has held multiple large research grants over the years and has led several multicenter academic and commercial studies. He has published over 200 peer reviewed scientific articles and book chapters. He has held several leadership roles including immediate past Secretary of UK Kidney Association, Chair of UK Kidney Research Consortium CKD and Diabetes Clinical Study Group, Co-Chair of Joint Association of British Clinical Diabetologists and UK Kidney association Committee, Expert Advisor to National Institute for Care and Clinical Excellence (NICE), and others. He is an Associate Editor of Clinical Medicine and Section Editor (Hypertension) of Current Opinion in Nephrology and Hypertension. David S GoldfarbDavid S GoldfarbDr Goldfarb is a Professor of Medicine and Physiology at NYU Grossman School of Medicine, New York, USA Clinical Chief of the Nephrology Division at NYU Langone Health, New York, USA and Chief of the Nephrology Section at the New York VA Medical Center in Manhattan, New York, USA. He serves as the Director of the Kidney Stone Prevention Program at NYU Langone and at New York VA Medical Center. He graduated from Yale College and the Yale School of Medicine, New Haven, USA and trained in Internal Medicine at New York VA and NYU, and Nephrology at New York University. He is the principal investigator of the Rare Kidney Stone Consortium's cystinuria project and served as the President of the NY Society of Nephrology (1999) and of the ROCK Society (Research on Calculus Kinetics, 2016). He was vice-chair of the American Urological Association's guideline panel, representing the American Society of Nephrology, on Medical Management of Kidney Stones, and co-authored the last set of guidelines. He earned a certificate from the Yale School of Public Health for their course on “Climate Change and Health”. He was selected as “Stone Crusher of the Year” in 2014 by the Oxalosis and Hyperoxaluria Foundation and “Nephrologist of the Year” in 2016 by the American Kidney Fund. He has had three calcium oxalate stones.